Nexavar's price drops by 30% & Teribone inj ↑31%

The MOHW promoted revised notification of pharmaceutical benefit list and upper limit price table in February

The price of Bayer Korea's anticancer drug Nexavar 200mg (Sorafenib tosylate) will be reduced by 30% next month.

 

It is a government control.

 

After that, at the end of the year, the benefits that have been given the premium will end and fall further.

 

The price of Dong-A ST's postmenopausal osteoporosis treatment Teribone inj 56.5μg (teriparatide) will rise by nearly 31% by the beginning of 2021.

 

According to industry sources on the 21st, the MOHW is pushing ahead with the revision of the 'pharmaceutical benefit list and upper limit price table'.

 

The actual application date differs for each item.

 

◆ End of addition = addition of Bayer Korea's Nexavar 200mg ends next month and the drug price drops by 30% The government has added 70% of the first listed products for one year from the date of the first generic registration, and then the addition is terminated.

 

However, even if one year has elapsed, if the number of companies for the same product is less than 3, the addition is maintained until 4 or more within the maximum range of 5 years.

 

The price to be cut next month will be ￦12,992 from ￦18,560.

 

After that, as the addition ends on December 1, the adjusted price is ￦9,939 from ￦12,992, down 23.5%.

 

◆Addition of new items = Paricalcitol, a vitamin from Huons, and Cefditoren pivoxil, a cephalosporin antibiotic from Kukje Pharma, will be reduced in price according to the end of the addition The government has given an increase of 59.5% for one year from the date of first generic registration and 68% for innovative pharmaceutical company, and then terminated.

 

The government adds 70% of the product to the product for one year from the date the generic is first listed and then ends the addition.

 

However, even if one year has elapsed, if the number of companies for the same product is less than 3, the addition is maintained until 4 or more within the maximum range of 5 years.

 

Huons' vitamin paricalcitol drops 21.2% from ￦15,309 to ￦12,056 from April 1st, and paricalcitol fine granule drops 9.9% from ￦647 to ￦583 from February 1st of next year.

 

◆Additional maintenance and termination = Donga ST’s Teribone inj 56.5μg will be added as of next month This is because the government maintains the addition when the number of companies under the same system is less than 3 even though the addition period has elapsed one year.

 

The price is 30.7% higher from the current ￦43,606 won to ￦57,001.

 

The end of the addition is February 1, 2023.

 

If the addition is maintained, the number of companies of the same product is applied until the number of companies of the same product is 3 or less, and when the number of companies of the same product is 4 or more.

 

The 4th~5th year is less than 3 companies, and the extension is decided every year after deliberation.

 

Teribone inj56.5μg insurance price adjusted in 2023 will drop 23.5%.